China Universal Asset Management Co., Ltd. Axsome Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 9,103 shares of AXSM stock, worth $730,151. This represents 0.09% of its overall portfolio holdings.
Number of Shares
9,103
Previous 9,103
-0.0%
Holding current value
$730,151
Previous $726,000
-0.0%
% of portfolio
0.09%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$360 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$256 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$189 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$105 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...